The global IoT infusion pumps market is experiencing significant growth driven by increasing demand for precision drug delivery, focus on medication error reduction & patient safety, growth of home infusion therapy. However, the lack of standardization and associated security and privacy concerns are slowing market evolution. Geographically, North America holds the largest share in this market, primarily due to its highly developed healthcare infrastructure that readily embraces cutting-edge medical technologies, strong emphasis on patient safety leading to high adoption rates of smart pumps with advanced features such as Dose Error Reduction Systems (DERS), and favorable regulatory and reimbursement policies that encourage innovation and market penetration. Furthermore, the significant burden of chronic diseases and the increasing trend towards home healthcare in the region also contribute to the demand for portable and user-friendly IoT-enabled infusion pumps. Conversely, the Asia-Pacific (APAC) region is experiencing the fastest growth, propelled by rapidly advancing healthcare infrastructure, particularly in populous emerging economies, increasing disposable income leading to greater healthcare spending, and a growing awareness of modern treatment modalities. Government initiatives and a notable shift towards home-based care models also play a crucial role in accelerating the adoption of IoT infusion pumps across APAC. Key players dominating this market include Baxter International Inc., B. Braun, and Medtronic plc, all of whom are actively investing in product innovation, strategic collaborations, and geographical expansion to solidify their market presence and capitalize on the evolving landscape of smart infusion therapy.
You can easily get a sample PDF of the report - https://www.businessmarketinsights.com/sample/BMIPUB00031912
IoT Infusion Pumps Market Drivers and Opportunities:
Increasing Demand for Precision Drug Delivery Driving IoT Infusion Pumps Market
Strongest drivers propelling the IoT infusion pumps market are the demand for precision drug delivery and the increased focus on patient safety and cost effectiveness in drug-related processes. Precision drug delivery systems are increasingly essential, there is now a rapid trend in healthcare towards the delivery of personalized medicine tailored to the needs of individual patients, their genetic make-up, and their real-time physiological response to therapies. Precision drug delivery systems are necessary to ensure the right dose, the right drug, the right process, and the right target site for their treatment within healthcare systems. IoT infusion pumps can reduce this need through the inclusion of functions such as dose error reduction systems (DERS), emergence of automated updates for drug libraries, and programmability for infusions. All of these programmed functions will decrease the use of manual processes, decrease medication waste, and lead to a measurable improvement in therapeutic result and outcome (e.g. the delivery of chemotherapy, pain medications, and even glucose for diabetes management) where small increases or decreases in drug dosage can meaningfully compromise safety or treatment efficacy to patients receiving those medications.
Development of Specialized & Wearable Infusion Systems
The emergence of specialized and wearable infusion systems represents a promising opportunity for the IoT infusion pumps market. Infusion therapy has already changed drastically and is different than when infusion pumps were large and stationary, and usually only allowed to be used in the hospital, or setting up to the patient mobility, and this often resulted in longer hospital stays. With the current rise in chronic diseases, the growing elderly population, and a clear preference for care at home with patients, there is a clear need and demand for clinical solutions which care for patients. Specialized pumps, in particular, highly portable ambulatory pumps, and inconspicuous wearable patch pumps, enable patients to receive any required medications such as insulin, antibiotics, or pain relief, at home or on the go! The possibility of patient convenience is increased with more possibilities afforded by IoT, which will allow convenient data collection and transmission, remote surveillance by a healthcare provider, automated Bluetooth features to adjust their doses as required, and overall improve adherence to treatment and lower the frequency of clinic visits, which improves quality of life in general. This shift towards having smaller, more convenient, and interconnected infusion devices opens additional pathways for growth in the market space. Wearable infusion pumps, for example, are made for simplicity of use and discretion. Most wearable pumps do away with the IV pole and large infusion devices, as a generalized example, consider the numerous advanced insulin patch pumps, which have Bluetooth connectivity, therefore no longer cumbersome.
IoT Infusion Pumps Market News and Key Development:
The IoT infusion pumps market is evaluated by gathering qualitative and quantitative data post primary and secondary research, which includes important corporate publications, association data, and databases. A few of the key developments in the IoT Infusion Pumps market are:
- Baxter International Inc. announced U.S. Food and Drug Administration (FDA) 510(k) clearance of its Novum IQ large volume infusion pump (LVP) with Dose IQ Safety Software. This addition expands the Novum IQ Infusion Platform, which already includes a syringe infusion pump, allowing clinicians to utilize a single, integrated system with shared innovative digital health solutions across various patient care settings for enhanced patient safety and efficiency. (Source: Baxter International Inc., Company Website, April 2024)
- ICU Medical Inc. announced 510(k) regulatory clearance from the U.S. Food and Drug Administration (FDA) for its Plum Solo precision IV pump, a single-channel complement to the dual-channel Plum Duo. They also received 510(k) clearance for updated versions of the Plum Duo precision IV pump and LifeShield infusion safety software. This marks the initial launch of their "IV Performance Platform" which aims to provide highly accurate and consistent medication delivery regardless of external factors, with full IV-EHR interoperability. (Source: ICU Medical Inc., Press Release, March 2025)
Get Premium Research Report at: https://www.businessmarketinsights.com/buy/BMIPUB00031912
About Us:
Business Market Insights is a market research platform that provides subscription service for industry and company reports. Our research team has extensive professional expertise in domains such as Electronics & Semiconductor; Aerospace & Defense; Automotive & Transportation; Energy & Power; Healthcare; Manufacturing & Construction; Food & Beverages; Chemicals & Materials; and Technology, Media, & Telecommunications.
Contact us:
- If you have any questions about this report or would like further information, please contact us:
- Contact person: Ankit Mathur
- Email: sales@businessmarketinsights.com
- Phone: +16467917070
